Study ID: C26401/1111 | 2013-001883-51
Study Title
- Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
Teva Identifier
- C26401/1111 | 2013-001883-51
ClinicalTrials.gov Identifier
- NCT01903824
Study Status
- Completed
Trial Condition(s)
- Cognitive Impairment
Interventions
- Drug: CEP-26401 | Drug: donepezil hydrochloride | Drug: modafinil | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 08/01/2013 - 12/01/2013
Phase
- Phase 1
Study Type
Interventional
